Skip to content

DR REDDYS LABORATORIES LTD

RDY

CIK 0001135951

← back to feed
Revenue (TTM)
3.81B
+13.8% YoY FY Mar 2026
Net Income (TTM)
671M
+0.4% YoY FY Mar 2026
EPS Diluted (TTM)
0.79
−80.3% YoY FY Mar 2026
Gross Margin
58.5%
FY Mar 2026
Operating Margin
22.1%
FY Mar 2026
Net Margin
17.6%
FY Mar 2026
Free Cash Flow (TTM)
—
FY Mar 2026
Cash
14.65B
FY Mar 2026
Total Debt
—
FY Mar 2026
Shares Outstanding
834.66M sh
FY Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings